Immunogenicity, Safety, Tolerability of a Plant-made H5 Virus-like-particle (VLP) Influenza Vaccine.

计划入组 390 人 · 首次发布于 2013 年 11 月 25 日

A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus

计划入组 116 人 · 首次发布于 2011 年 7 月 29 日

A/Texas Flu Challenge

计划入组 50 人 · 首次发布于 2024 年 12 月 31 日

Influenza A virus A/Uruguay/716/2007(H3N2) live (attenuated) antigen

influenza virus vaccine

Influenza A virus A/Brisbane/10/2010 live (attenuated) antigen

Research Institute of Influenza

Russia

A&A SMALL CHANGES HANDYPEOPLE

United States

Novozymes A/S

Denmark

Clinical Trial Evaluating Safety and Immunogenicity of Bird Flu Vaccines

Applied DNA Sciences Seeks NYSDOH Approval for Novel H5 Bird Flu Diagnostic Test

Boehringer Ingelheim Introduces Novel Trivalent Vaccine Combining H5 Avian Flu Protection with Core Poultry Immunizations